<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043923</article-id><article-id pub-id-type="pmc">6089130</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0169</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Heat Shock Proteins: Protection and Potential Biomarkers for Ischemic
Injury of Cardiomyocytes After Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Santos-Junior</surname><given-names>Valfredo de Almeida</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MSc</role></contrib><contrib contrib-type="author"><name><surname>Lollo</surname><given-names>Pablo Christiano Barboza</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Cantero</surname><given-names>Marcos Antonio</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Moura</surname><given-names>Carolina Soares</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Amaya-Farfan</surname><given-names>Jaime</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Morato</surname><given-names>Priscila Neder</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MSc, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Faculdade de Engenharia de Alimentos (FEA) da Universidade Estadual
de Campinas (Unicamp), Campinas, SP, Brazil.</aff><aff id="aff2">
<label>2</label>Faculdade de Ci&#x000ea;ncias da Sa&#x000fa;de (FCS) da Universidade
Federal da Grande Dourados (UFGD), Dourados, MS, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Valfredo de Almeida Santos-Junior,
Universidade Estadual de Campinas, Rua Monteiro Lobato, 80, FEA/Unicamp -
Campinas, SP, Brazil - Zip code: 13083-862. E-mail:
<email>juniorfex@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>291</fpage><lpage>302</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>The heat shock proteins are endogenous proteins with the ability to act as
molecular chaperones. Methods that provide cell protection by way of some damage
can positively influence the results of surgery. The present review summarizes
current knowledge concerning the cardioprotective role of the heat shock
proteins as occurs in heart damage, including relevant information about the
stresses that regulate the expression of these proteins and their potential role
as biomarkers of heart disease.</p></abstract><kwd-group><kwd>Heat-shock response</kwd><kwd>Cytoprotection</kwd><kwd>Biomarkers</kwd><kwd>Myocardium</kwd><kwd>Infarction</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GGC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Geranylgeranylacetone</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HSPs</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Heat shock proteins</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Heat shock proteins (HSPs) are a family of endogenous proteins responsible for a
variety of stresses. The are classified according to their molecular weights in
families, <italic>e.g</italic>. HSP27, HSP70, etc.<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>. They have the ability
to act as 'molecular chaperones', since they stabilize macromolecules, guide protein
folding, perform the refolding and remove irreversibly denatured proteins in the
cell<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>-</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>.</p><p>The HSPs can be overexpressed in various stress situations, such as
hyperthermia<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>, hemodynamic stress caused by heart
diseases<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>, physical exercise<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>, the administration of
some substances as geranylgeranylacetone<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup> and glutamine<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>, among others.</p><p>Heart surgery improves the survival and clinical prognosis of various diseases, but
can induce an ischemic/reperfusion condition that damages the cardiac tissue.
Methods that induce heart protection by ischemic damage can positively influence the
result of surgery. Some HSPs have been the target of studies because they increase
the resistance of myocardium cells against ischemia<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>-</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>. Other studies
verified the relationship between HSPs and the development of heart
disease<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>-</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. Since failures in the detection of heart diseases
can worsen the odds, more sensitive methods could significantly increase patient
survival.</p><p>The expression of HSPs in the heart has been the focus of several studies, but some
questions still need clarification, such as: do all HSPs have a protective effect?
Would increases in HSPs serve as new biomarkers for the diagnosis/prognosis of
cardiovascular diseases? Would the increase offer advantages/improvements in the
clinical outcome of cardiovascular diseases? As from these doubts, the objective of
the present study was to systematically analyze the published studies concerning the
expression of HSPs in the heart.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The literature survey was carried out based on the PubMed data using the descriptors
"Heat shock protein" and "heart" as components of the search field title. The
objective was to select articles that researched the expression of HSPs specifically
in the heart. We found 90 articles, among which those that included the objectives
of the search were selected, excluding articles in languages other than English, and
texts that were not complete articles or made conclusions about other
substances/means or that did not report directly on the problems/cardiac tissues
(<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram showing the inclusion and exclusion criteria of the
articles.</p></caption><graphic xlink:href="rbccv-33-03-0291-g01"/></fig>
</p></sec><sec><title>RESULTS AND DISCUSSION</title><sec><title>HSPs and Heart Protection</title><p>HSP70 and some other small heat shock proteins (sHSPs) were found to provide
heart protection. Of the 69 articles included in this study, 26 dealt with the
effect of the HSPs in heart protection and 25 showed that the presence of these
proteins was associated with the protective effect in cardiac
tissue<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>-</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>,</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>-</sup><sup><xref rid="r36" ref-type="bibr">36</xref></sup><sup>]</sup>.</p><p>Part of the myocardial protection granted, according to the authors, was due to
the effect of HSP70 in response to ischemic damage. Yamashita et
al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup> and Kukreja et al.<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup> induced the
superexpression of HSP70, thus obtaining a significant reduction in the
infarcted area. Qian et al.<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>, Okubo et al.<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>, Vittorini et
al.<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>, Zhao et al.<sup>[</sup><sup><xref rid="r32" ref-type="bibr">32</xref></sup><sup>]</sup> and Li et
al.<sup>[</sup><sup><xref rid="r34" ref-type="bibr">34</xref></sup><sup>]</sup> reported similar results. Additionally,
Yamashita et al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup> showed that HSP70 content correlated with the
time course of cardioprotection. Furthermore, an increase in HSP70 expression
can prevent lipopolysaccharide-induced dysfunction<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. Only Xi et
al.<sup>[</sup><sup><xref rid="r37" ref-type="bibr">37</xref></sup><sup>]</sup> did not observe diferences in infarct size
between the HSP70 and control groups.</p><p>In addition to the decrease in the infarcted area, an increase in the expression
of HSP70 offers an improvement in the recovery of post-ischemia/reperfusion
injury<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>,</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>,</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>,</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup>. Nomura et al.<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup> verified that
upregulation of HSP70 before cardioplegic ischemia improved the recovery of
systolic and coronary endothelian function. Ooie et al.<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup> demonstrated that
an increase in HSP70 expression induced by geranylgeranylacetone (GGC)
significantly improved post-ischemia heart recovery and decreased the cardiac
injury markers.</p><p>Tanonaka et al.<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup> demonstrated that an increase in HSP70 was
inversely correlated with worsening of cardiac parameters. However, an infarcted
heart appears to have a lower production capacity of HSP70, which could be
intimately related to its functional deterioration and ability to tolerate
further damage<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. An increase of HSP70 expression is also
correlated with a decrease in heart apoptosis<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>,</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>]</sup>. Both authors
explored the expression of this protein as related to changes in endogenous
hormones, but the role of these hormones on the expression of HSP70 is still
unclear.</p><p>In addition, sHSPs also promote heart protection<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>,</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>,</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>,</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>,</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>,</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>,</sup><sup><xref rid="r33" ref-type="bibr">33</xref></sup><sup>,</sup><sup><xref rid="r35" ref-type="bibr">35</xref></sup><sup>]</sup>. Kim et
al.<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>, Efthymiou et al.<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup> and Kwon et
al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup> found that HSP27 offered a protective effect in
cases of infarction. Groups that overexpressed HSP27 presented significant
reductions in the infarcted areas and reductions in cell apoptosis in cardiac
tissue. Zhu and Wang<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup> observed these same characteristics with
increased expression of HSP20.</p><p>Chen et al.<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup> reveals that type-1 diabetic hearts are
resistant to ischemic injury by upregulation of phosphorylated HSP27 and the low
expression of HSP27 was associated with atrial fibrillation in patients with
rheumatic heart disease<sup>[</sup><sup><xref rid="r36" ref-type="bibr">36</xref></sup><sup>]</sup>. An increase in the expression of HSP27
also provided an increase in the efficiency of stem cell therapy in the
myocardial recovery, decreasing cell apoptosis and improving heart recovery
during therapy<sup>[</sup><sup><xref rid="r35" ref-type="bibr">35</xref></sup><sup>]</sup>.</p><p>Jiang et al.<sup>[</sup><sup><xref rid="r33" ref-type="bibr">33</xref></sup><sup>]</sup> obtained similar results with increased
expression of HSP32, which promoted heart protection following
ischemia/reperfusion. An increase in the expression of HSP25 improved survival
in patients with cardiomyopathy and increased heart resistance against
toxicity<sup>[</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>]</sup>.</p></sec><sec><title>Induction of the Expression of HSPs</title><p>Hyperthermia is one of the main and best known inducers of HSP expression, and of
the articles included in this systematic review, twelve used this method to
increase the protein expression<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>-</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>,</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>-</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>,</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>,</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>,</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>,</sup><sup><xref rid="r37" ref-type="bibr">37</xref></sup><sup>-</sup><sup><xref rid="r39" ref-type="bibr">39</xref></sup><sup>]</sup>. However, depending on tissue type and HSP,
increased expression can be influenced by several other types of stress, as
shown in the general scheme of <xref ref-type="fig" rid="f2">Figure
2</xref>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>General scheme of some of the physiological signals that activate the
inducible form of the heat shock protein (HSP) in the cardiac cell.
Physiological stress is required to enable access to heat shock
factor-1 (HSF-1) complex present in the cytosol, allowing its
phosphorylation (P) by protein kinases to their active form. These
HSF-1 phosphorylated complexes enter the nucleus and bind to heat
shock elements (HSE) in the promoter region of the HSP-especific
gene. Transcriptional and translational processes increase HSP
expression in the cellular cytosol.</p></caption><graphic xlink:href="rbccv-33-03-0291-g02"/></fig>
</p></sec><sec><title>HSP70</title><p>Some substances also influence the regulation of HSP70: circulating hormones like
phenyleprine and vasopressin<sup>[</sup><sup><xref rid="r38" ref-type="bibr">38</xref></sup><sup>]</sup>, free radicals<sup>[</sup><sup><xref rid="r40" ref-type="bibr">40</xref></sup><sup>]</sup>, treatment with
geranylgeranylcetone<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>, liposomal protein delivery of
HSP70<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>, intravenous injection of
anandamide<sup>[</sup><sup><xref rid="r34" ref-type="bibr">34</xref></sup><sup>]</sup>, chronic administration of <italic>Terminalia
arjuna</italic><sup>[</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup>, injection of HSP70
adenovirus<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>, probiotic-derived
proteins<sup>[</sup><sup><xref rid="r32" ref-type="bibr">32</xref></sup><sup>]</sup> and parenteral administration of
glutamine<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>. All these were shown to be effective in
increasing the expression of this protein.</p><p>Pathologies induce systematic stress that could superexpress HSP70 in the heart.
Wei et al.<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup> verified that the protein expression of HSP70
is frequently increased in hearts showing failure due to arrhythmogenic
cardiomyopathy, dilated cardiomyopathy and ischemia. Ferrari et
al.<sup>[</sup><sup><xref rid="r41" ref-type="bibr">41</xref></sup><sup>]</sup> verified that congestive heart failure
increases HSP72 expression more pronounced in right than left ventricles,
whereas hibernation increases expression in both. The initial stages of heart
failure<sup>[</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>,</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>]</sup>, elevation of aortic
pressure<sup>[</sup><sup><xref rid="r44" ref-type="bibr">44</xref></sup><sup>]</sup> and diabetes mellitus<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup> increase the
expression of HSP70 in the heart tissue as a form of protection.</p><p>However, as failure proceeds, repression of the nuclear portion of HSF-1 (heat
shock factor 1) ensues thus inhibiting the expression of HSP70 in the more
serious stages of the disease<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>,</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>-</sup><sup><xref rid="r46" ref-type="bibr">46</xref></sup><sup>]</sup>. Two studies verified the involvement of
diabetes mellitus in HSP70 expression<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>,</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup>. Ugurlucan et
al.<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup> demonstrated an increase of HSP70 in diabetic
hearts, while Chen et al.<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup> observed no differences between the control
and diabetic groups. Further research is essential to clarify the effects of
diabetes mellitus on the expression of HSP70 in the heart.</p><p>Steroid hormones alter the expression of HSP70 differently in men and women.
Treatment with 17-B-estradiol or progesterone can activate HSF-1 and
consequently increase the HSP70 expression, but not of the other
HSPs<sup>[</sup><sup><xref rid="r47" ref-type="bibr">47</xref></sup><sup>]</sup>. Shinohara et al.<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup> found that male
hearts are more sensitive to the induction of HSP70 and the author explained
that this finding was due to the inhibitory effect of estrogen on the HSP70
expression. However, Kohno et al.<sup>[</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>]</sup> showed that testosterone also had
an inhibitory effect on the expression of HSP70, this inhibition being mediated
by testosterone receptors in the heart tissue. Further research is required in
this field, since the analysis of the results of these two studies seems to
indicate that both sex hormones have an inhibitory effect, although estrogen may
be a more potent inhibitor than testosterone, unless other factors are involved
in the regulation process.</p><p>The stress produced by the heart surgery itself has been shown to induce an
increase in HSP70 expression. Schmitt et al.<sup>[</sup><sup><xref rid="r48" ref-type="bibr">48</xref></sup><sup>]</sup> reported a
superexpression of HSP70 after stress caused by cardioplegic arrest, which was
proportional to the duration of the cardioplegia. The increase became more
pronounced after two hours, leading to the conclusion that the synthesis peaks
at about two hours in human hearts. There were no significant changes in the
HSPs of other molecular weights.</p><p>Similar results were found by Vittorini et al.<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup> and Dybdahl et
al.<sup>[</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>]</sup>, who observed that cardioplegia positively
regulated the expression of HSP70. Ischemia/reperfusion preconditioning
upregulates the HSP70 expression<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>,</sup><sup><xref rid="r50" ref-type="bibr">50</xref></sup><sup>]</sup>. Hypothermic cardioplegia showed increase
the HSP70 expression even more than normothermic controls, but only one study
tested this hypothesis and this topic needs more research<sup>[</sup><sup><xref rid="r51" ref-type="bibr">51</xref></sup><sup>]</sup>.</p><p>Other types of cardiac stress have been shown to be efficient in increasing HSP70
expression, such as height-induced hypoxia, remaining high for up to two
weeks<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup> or pulmonar artery
banding<sup>[</sup><sup><xref rid="r52" ref-type="bibr">52</xref></sup><sup>]</sup>, a single stretch and fiber
shortening<sup>[</sup><sup><xref rid="r53" ref-type="bibr">53</xref></sup><sup>]</sup>, physical exercise<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup> and stress caused by
environmental changes<sup>[</sup><sup><xref rid="r54" ref-type="bibr">54</xref></sup><sup>]</sup>.</p></sec><sec><title>HSP60</title><p>The increase in HSP60 expression due to hyperthermia is tissue-specific. Yan et
al.<sup>[</sup><sup><xref rid="r55" ref-type="bibr">55</xref></sup><sup>]</sup>, verified the behavior of HSP60 under acute
heat conditions and showed that the expression was tissue-specific and that the
increase was related to the extent of damage to the tissue. In the heart, HSP60
started increasing after one hour of induction and reached a peak after five
hours.</p><p>On analyzing the protein expression induced by the development of heart failure,
Tanonaka et al.<sup>[</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>]</sup> showed that HSP60 levels only increased in the
eighth week, when functional changes occurred that defined the presence of the
pathology. Hoppichler et al.<sup>[</sup><sup><xref rid="r56" ref-type="bibr">56</xref></sup><sup>]</sup> found an increase in HSP60 antibodies in
chronic heart disease. Wang et al.<sup>[</sup><sup><xref rid="r46" ref-type="bibr">46</xref></sup><sup>]</sup> demonstrated that the increase in
HSP60 during heart failure could be mediated by the increase in circulating
NFkB. In the reviewed articles, only three dealt with forms of inducing HSP60
expression.</p></sec><sec><title>Small Heat Shock Protein (HSP20, 25 and 27)</title><p>Stress induced by some diseases affects the expression of HSP27 and some other
HSPs. Tanonaka et al.<sup>[</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>]</sup> found that at the onset of heart failure there
was an increase in HSP27. Corroborating the finding above, Dohke et
al.<sup>[</sup><sup><xref rid="r57" ref-type="bibr">57</xref></sup><sup>]</sup> observed an increase in phosphorylation of
HSP20 and HSP27. Ischemic preconditioning also increases HSP27
expression<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>. Hu et al.<sup>[</sup><sup><xref rid="r58" ref-type="bibr">58</xref></sup><sup>]</sup> demonstrated a
reduction in the expressions of HSP27 and HSP32 in the heart following
intracerebral hemorrhage, but treatment with deferoxamine reversed the reduction
in HSP32, although making the reduction in HSP27 even more pronounced.</p><p>Raju et al.<sup>[</sup><sup><xref rid="r45" ref-type="bibr">45</xref></sup><sup>]</sup> observed that congestive heart failure
increases HSP32 without changing HSP70 expression, showing that HSPs behave in
distinct manners with each other. The regulation of some sHSP may be correlated
with endogenous proteins. As published by Jiang et al.<sup>[</sup><sup><xref rid="r33" ref-type="bibr">33</xref></sup><sup>]</sup>, nucleolin
interacts with the mRNA of HSP32 increasing its stability and consequently its
expression.</p><p>McGinley et al.<sup>[</sup><sup><xref rid="r35" ref-type="bibr">35</xref></sup><sup>]</sup> noted that it was possible to increase the
expression of HSP27 by treating with lentivirus vectors, an effect similar to
that demonstrated by Kwon et al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>, which induced an increase in HSP27 using a
protein delivery system by recombinant HSP27 linked to a protein transduction
domain. The adenoviruses HSP20 and HSP22 were also efficient in increasing the
expression of these proteins in cardiomyocytes<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup>. Pretreatment with
HSP25 enriched plasma also induced an increase in the expression of
extracellular HSP25, according to a study published by Krishnamurthy et
al.<sup>[</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>]</sup>.</p><p>Systemic stress positively regulate the expression of HSPs. Physical exercise
increased the expression of HSP27<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>, and Boluyt et al.<sup>[</sup><sup><xref rid="r59" ref-type="bibr">59</xref></sup><sup>]</sup> showed that only
chronic physical training caused an increase in HSP20 expression, which
persisted for at least 72 hours of detraining. Stresses such as drug abstinence
induced an increase in HSP, as verified by the work of Almela et
al.<sup>[</sup><sup><xref rid="r60" ref-type="bibr">60</xref></sup><sup>]</sup>, where morphine-dependent rats showed an
increase in HSP27 expression upon receiving saline instead of morphine.</p></sec><sec><title>HSPs as Potential Biomarkers for Heart Disease</title><p>Due to their characteristic response to diverse stresses, including heart
disease, the power of HSPs as diagnostic and prognostic markers for heart
disease has been investigated. Of the papers included in this study, 21 of them
verified this relationship<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>,</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>,</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>,</sup><sup><xref rid="r45" ref-type="bibr">45</xref></sup><sup>,</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>,</sup><sup><xref rid="r56" ref-type="bibr">56</xref></sup><sup>,</sup><sup><xref rid="r57" ref-type="bibr">57</xref></sup><sup>,</sup><sup><xref rid="r61" ref-type="bibr">61</xref></sup><sup>-</sup><sup><xref rid="r72" ref-type="bibr">72</xref></sup><sup>]</sup>.</p><p>Of these studies, nine investigated the relationship of HSP60 expression and its
potential to detect heart disease, and seven of them showed that HSP60 had the
potential to be a diagnostic or prognostic marker of heart disease. Veres et
al.<sup>[</sup><sup><xref rid="r64" ref-type="bibr">64</xref></sup><sup>]</sup> and Zhang et al.<sup>[</sup><sup><xref rid="r70" ref-type="bibr">70</xref></sup><sup>]</sup> verified that high
levels of HSP60 could increase the risk of heart disease and could be considered
as a new familial risk factor for these diseases.</p><p>Elevated HSP60 concentrations were positively associated with the severity of
coronary arterial disease in a dose-dependent way<sup>[</sup><sup><xref rid="r70" ref-type="bibr">70</xref></sup><sup>,</sup><sup><xref rid="r71" ref-type="bibr">71</xref></sup><sup>]</sup> and with ischemic
heart disease<sup>[</sup><sup><xref rid="r68" ref-type="bibr">68</xref></sup><sup>]</sup>, and also showed a correlation with heart
failure and other adverse cardiac events and antibodies levels in sera can be
correlated with worse prognosis<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>,</sup><sup><xref rid="r61" ref-type="bibr">61</xref></sup><sup>,</sup><sup><xref rid="r69" ref-type="bibr">69</xref></sup><sup>]</sup>. Only Hoppichler et
al.<sup>[</sup><sup><xref rid="r56" ref-type="bibr">56</xref></sup><sup>]</sup> and Rothenbacher et al.<sup>[</sup><sup><xref rid="r63" ref-type="bibr">63</xref></sup><sup>]</sup> reported that high
levels of HSP60 did not correlate with the risk factor for heart disease.</p><p>Of the ten studies that verified the role of HSP70 as a possible biomarker for
heart disease, nine came to a positive conclusion. The pioneering work of Comini
et al.<sup>[</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>]</sup> was confirmed by Genth-Zotz et
al.<sup>[</sup><sup><xref rid="r65" ref-type="bibr">65</xref></sup><sup>]</sup> and Gombos et al.<sup>[</sup><sup><xref rid="r67" ref-type="bibr">67</xref></sup><sup>]</sup>, who found that
the levels of this protein were significantly higher in the groups with heart
failure and that this expression was related to the severity of the disease. In
agreement with those reports, Wei et al.<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup> also observed that an increase in
the expression of HSP70 was common in heart failure.</p><p>Comini et al.<sup>[</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>]</sup> showed that congestive heart failure, but not
compensatory hypertrophy, increases HSP70 expression in heart. Only Raju et
al.<sup>[</sup><sup><xref rid="r45" ref-type="bibr">45</xref></sup><sup>]</sup> found no changes in HSP70 expression in the
congestive heart failure model. Patients with myorcardial infarction also show
higher levels of HSP70 than control subjects<sup>[</sup><sup><xref rid="r66" ref-type="bibr">66</xref></sup><sup>]</sup>. Another fact that
supports its use as a diagnostic/prognostic biomarker of heart disease is the
correlation that has been reported between HSP70 and the traditional injury
markers such as AST, ALT, &#x003b3;GT and bilirubin in patients with heart
failure<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r67" ref-type="bibr">67</xref></sup><sup>]</sup>.</p><p>In assessing the relationship between HSP70 and progression of heart failure, Li
et al.<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup> verified a significant increase with the
progression of disease stages, showing their potential for detection, mainly in
old myocardial infarction or in those whith structural heart disease. Baba et
al.<sup>[</sup><sup><xref rid="r62" ref-type="bibr">62</xref></sup><sup>]</sup> concluded that worse parameters correlate with
increased HSP70 and that this increase was inversely correlated with rejection
in the case of heart transplantation. Dybdahl et al.<sup>[</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>]</sup> concluded that
measurement of increased levels of HSP70 in post-cardiac surgery tissue and
ischemia could offer an advantage in the diagnosis and prognosis of such
cases.</p><p>Increased sHSPs are also correlated with heart failure, and HSP27 can be used as
a marker for this purpose. It was shown that HSP20, HSP27 and HSP32 were
involved in congestive heart failure due to significant increases in the
phosphorylated forms that appear in this disease<sup>[</sup><sup><xref rid="r45" ref-type="bibr">45</xref></sup><sup>,</sup><sup><xref rid="r57" ref-type="bibr">57</xref></sup><sup>]</sup>. An increase in
HSP27 was correlated with the progression of heart failure in
animals<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>, and in humans HSP27 was significantly higher
in patients with valvular heart disease<sup>[</sup><sup><xref rid="r72" ref-type="bibr">72</xref></sup><sup>]</sup>, suggesting its use as a marker
for disease.</p></sec><sec><title>Influence of HSP on Heart Health</title><p>HSPs work as a cellular defense mechanism, acting as a complementary antioxidant
system; the oxidative stress inducing an increase in the expression of one or
several HSPs, and this increase in turn promotes
protection<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup> through repairing. The accumulation of reactive
oxygen species throughout a lifetime, however, can affect the efficiency and
homeostasis of the cellular system.</p><p>Ageing negatively affects HSP70 expression in the heart, leaving the heart more
susceptible to oxidative damage, but Rinaldi et al.<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup> showed that physical
exercise increased the expression of HSP70 and HSP27 in the heart. In fact, the
expression of these proteins inhibits apoptosis and protects the integrity of
actin and cardiac microtubule cytoskeleton<sup>[</sup><sup><xref rid="r46" ref-type="bibr">46</xref></sup><sup>]</sup>, thus explaining in part the
beneficial effect of exercise on the heart of the elderly.</p><p>HSP70 is an endogenous activator of the innate immune
system<sup>[</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>,</sup><sup><xref rid="r66" ref-type="bibr">66</xref></sup><sup>]</sup>. The circulating levels of HSP70 not only act
as molecular chaperones but are also correlated with the decrease of
inflammatory cytokines. An <italic>in vitro</italic> study proved the release of
inflammatory cytokines mediated by HSP70, TLR4 receptor
agonists<sup>[</sup><sup><xref rid="r66" ref-type="bibr">66</xref></sup><sup>]</sup>. Dybdahl et al.<sup>[</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>]</sup> found that HSP70
did, in fact, induce an increase in IL-6 and TNF in a dose-dependent manner
<italic>via</italic> TLR4/CD14, thus demonstrating the involvement of HSP70
in the inflammatory response.</p><p>Besides guiding the initial protein folding, some small heat shock proteins help
in heart protection and function. Qiu et al.<sup>[</sup><sup><xref rid="r73" ref-type="bibr">73</xref></sup><sup>]</sup> demonstrated that
HSP22 depletion did not affect heart function under basal conditions, but
following cardiac overload, its absence promoted eccentric hypertrophy and
dilation of the heart, accelerated the transition to heart failure, and
interfered in the activation of the cellular protection system.</p><p>Additionally, an increase in HSP25 expression can prevent apoptosis signaling,
antagonizing the activation of TLR2 after systemic stress, such as in the case
of toxic treatments or the accumulation of denatured
proteins<sup>[</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>]</sup>. HSP20 positively interferes in the contractile
capacity of the heart; the overexpression of HSP20 is a beneficial factor for
heart tissue, since it acts in the cellular protection against several types of
stress and simultaneously improves the contractile
function<sup>[</sup><sup><xref rid="r59" ref-type="bibr">59</xref></sup><sup>]</sup>.</p><p>
<xref rid="t1" ref-type="table">Table 1</xref> presents a summary of the
evidence.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of evidence.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="45%" span="1"/><col width="45%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Objective</th><th align="center" rowspan="1" colspan="1">Results/Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Almela et al.<sup>[</sup><sup><xref rid="r60" ref-type="bibr">60</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the HSP27 expression during
morphine dependence and withdrawal</td><td align="center" rowspan="1" colspan="1">Morphine withdrawal &#x02191;HSP27 in heart</td></tr><tr><td align="left" rowspan="1" colspan="1">Baba et al.<sup>[</sup><sup><xref rid="r62" ref-type="bibr">62</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the correlation between hemodynamic
parameters and HSP70 in the early period after heart
transplantation</td><td align="center" rowspan="1" colspan="1">Worsening of the parameters is correlated with
&#x02191;HSP70 / Patients who died and in case of transplant
rejection was observed more &#x02191;HSP / <break/>&#x02191;HSP70
was inversely correlated with rejection</td></tr><tr><td align="left" rowspan="1" colspan="1">Boluyt et al.<sup>[</sup><sup><xref rid="r59" ref-type="bibr">59</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the protein changes in the heart
after physical training</td><td align="center" rowspan="1" colspan="1">Chronic physical training &#x02191;HSP20 /
&#x02191;HSP20 can stay up to 72h after physical training</td></tr><tr><td align="left" rowspan="1" colspan="1">Bonanad et al.<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To evaluate the correlation between HSP60 and the
risk of death/recurrence of acute HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 related to risk of
death/recurrence</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen et al.<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the response of HSPs and tolerance
of type 1 diabetic hearts to ischemia/reperfusion injury</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 phosphorylated and &#x02191;injury
tolerance in diabetic hearts / &#x02194;HSP70 in diabetic hearts</td></tr><tr><td align="left" rowspan="1" colspan="1">Comini et al.<sup>[</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the HSP70 expression in lungs,
liver, cardiac and skeletal muscle in congestive heart
failure</td><td align="center" rowspan="1" colspan="1">CHF, but not compensatory hypertrophy
&#x02191;HSP70 in heart</td></tr><tr><td align="left" rowspan="1" colspan="1">Dohke et al.<sup>[</sup><sup><xref rid="r57" ref-type="bibr">57</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To evaluate the change of protein expression in
HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 and &#x02191;HSP20 in hearts with
HF</td></tr><tr><td align="left" rowspan="1" colspan="1">Dybdahl et al.<sup>[</sup><sup><xref rid="r49" ref-type="bibr">49</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To explore the release of HSP70 after CABG</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 release after CABG / &#x02191;HSP70
related to &#x02191;IL-6 and &#x02191;TNF</td></tr><tr><td align="left" rowspan="1" colspan="1">Efthymiou et al.<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the heart response overexpressing
HSP27 to ischemia/reperfusion injury</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 &#x02193;the infarct size / &#x02191;
HSP27 protected the heart from ischemia/reperfusion injury</td></tr><tr><td align="left" rowspan="1" colspan="1">Ferrari et al.<sup>[</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To compare myocardial hibernation and congestive
heart failure in HSP72 expression</td><td align="center" rowspan="1" colspan="1">Myocardial hibernation &#x02191;HSP72 in right and
left ventricles / Congestive heart failure &#x02191;HSP72 more
marked in the right than in the left ventricle</td></tr><tr><td align="left" rowspan="1" colspan="1">Gauthaman et al.<sup>[</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of <italic>Terminalia
arjuna</italic> (TA) on HSP expression and its influence on
ischemic damage</td><td align="center" rowspan="1" colspan="1"><italic>Terminalia arjuna</italic> treatment
&#x02191;HSP72 / Treatment &#x02191;the recovery of cardiac
function after ischemia/reperfusion</td></tr><tr><td align="left" rowspan="1" colspan="1">Genth-Zotz et al.<sup>[</sup><sup><xref rid="r65" ref-type="bibr">65</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the circulating HSP70 levels in
patients with CHF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 in CHF patients / &#x02191;HSP70
related to disease severity</td></tr><tr><td align="left" rowspan="1" colspan="1">Gombos et al.<sup>[</sup><sup><xref rid="r67" ref-type="bibr">67</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the clinical and biological
correlation of HSP70 in HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 levels were associated with disease
severity in HF patients / &#x02191;HSP70 correlated with markers
of cardiac function and liver injury</td></tr><tr><td align="left" rowspan="1" colspan="1">Gray et al.<sup>[</sup><sup><xref rid="r51" ref-type="bibr">51</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">Investigate the effect of hypothermic
cardioplegic arrest in the expression of HSP70</td><td align="center" rowspan="1" colspan="1">The hypothermic cardioplegic &#x02191;HSP70 more
than normothermic control</td></tr><tr><td align="left" rowspan="1" colspan="1">Hoppichler et al.<sup>[</sup><sup><xref rid="r56" ref-type="bibr">56</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the association between HSP60
antibodies with coronary heart disease and acute myocardial
infarction</td><td align="center" rowspan="1" colspan="1">CHD &#x02193;HSP60 / Myocardial infarction
&#x02193;HSP60 antibodies compared to CHD</td></tr><tr><td align="left" rowspan="1" colspan="1">Hu et al.<sup>[</sup><sup><xref rid="r58" ref-type="bibr">58</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the expression of HSPs in the heart
after ICH</td><td align="center" rowspan="1" colspan="1">ICH &#x02193;HSP27 and &#x02193;HSP32 in the
heart</td></tr><tr><td align="left" rowspan="1" colspan="1">Jafarzadeh et al.<sup>[</sup><sup><xref rid="r68" ref-type="bibr">68</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To evaluate HSP60 in patients with ischemic heart
disease</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 in the groups of patients compared
to control groups</td></tr><tr><td align="left" rowspan="1" colspan="1">Jiang et al.<sup>[</sup><sup><xref rid="r33" ref-type="bibr">33</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the role of nucleolin in cardiac
ischemia/reperfusion injury</td><td align="center" rowspan="1" colspan="1">Nucleolin &#x02191;HSP32 / &#x02191;HSP32 offers
cardiac protection</td></tr><tr><td align="left" rowspan="1" colspan="1">Katayose et al.<sup>[</sup><sup><xref rid="r52" ref-type="bibr">52</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the expression of heme oxygenase
(HSP32) and HSP70 in hearts subjected to hypoxia or pulmonary
artery banding</td><td align="center" rowspan="1" colspan="1">Hypoxia &#x02191;HSP32 e &#x02194;HSP70 in right and left
ventricle / Pulmonary artery banding &#x02191;HSP32 and
&#x02191;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Kim et al.<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine whether extracellular kinases are
upregulated by preconditioning and whether they are required for
cadioprotection</td><td align="center" rowspan="1" colspan="1">Preconditioning &#x02191;HSP27 and &#x02193;infarct
size</td></tr><tr><td align="left" rowspan="1" colspan="1">Knowlton and Sun<sup>[</sup><sup><xref rid="r47" ref-type="bibr">47</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the relationship between HSPs and
hormone receptors</td><td align="center" rowspan="1" colspan="1">17-B-estradiol or progesterone &#x02191;HSF-1 and
&#x02191;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Knowlton et al.<sup>[</sup><sup><xref rid="r53" ref-type="bibr">53</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of decreased systolic
shortening and a single stretch on HSP70 expression</td><td align="center" rowspan="1" colspan="1">Single stretch and fiber shortening
&#x02191;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Kohno et al.<sup>[</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effects of testosterone on
HSP72 expression and its relation to cardioprotection</td><td align="center" rowspan="1" colspan="1">Exogenous testosterone &#x02193;HSP72 after heat
stress / &#x02191;&#x000a0;HSP72 correlates &#x02193;cardiac apoptosis and
&#x02191;functional recovery</td></tr><tr><td align="left" rowspan="1" colspan="1">Krishanarmurthy et al.<sup>[</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the relationship between HSP25 and
protection against cardiotoxicity</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP25 protected the heart from
cardiotoxicity</td></tr><tr><td align="left" rowspan="1" colspan="1">Kukreja et al.<sup>[</sup><sup><xref rid="r41" ref-type="bibr">41</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the influence of free radicals on
HSP70 expression in the heart</td><td align="center" rowspan="1" colspan="1">Free radicals &#x02191;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Kukreja et al.<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To verify the hypothesis that inhibition of
protein kinase C would block the cardioprotection mediated by
heat stress </td><td align="center" rowspan="1" colspan="1">Heat stress &#x02191;HSP70 and &#x02193;infarct
size / PKC inhibitor <break/> &#x02193;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Kwon et al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To evaluate the efficacy of an intracellular
delivery system in the expression of HSP27 and in cardiac
protection</td><td align="center" rowspan="1" colspan="1">Intracellular delivery system &#x02191;HSP27 /
&#x02191;HSP27 <break/> &#x02193;apoptosis and &#x02193;size of the
infarcted area / &#x02191;HSP27 promotes heart protection against
ischemia</td></tr><tr><td align="left" rowspan="1" colspan="1">Latif et al.<sup>[</sup><sup><xref rid="r61" ref-type="bibr">61</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To quantify levels of circulating anti-HSP60
antibodies in the cardiac transplant patient </td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 antibodies in sera appear to have a
worse prognosis</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et al.<sup>[</sup><sup><xref rid="r34" ref-type="bibr">34</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To test the effect of anandamide in HSP72
expression and cardioprotection</td><td align="center" rowspan="1" colspan="1">Anadamide &#x02191;HSP70 and protect the heart
against ischemia/reperfusion injury</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et al.<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To characterize the expression of circulating HSP
in HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 and &#x02191;HSP70 in animals and
&#x02191;HSP70 in humans with HF / &#x02191;HSP70 with progression
of HF</td></tr><tr><td align="left" rowspan="1" colspan="1">Marunouchi et al.<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To analyze the HSF-1 and HSP70 kinetics after
HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP72 and &#x02191;HSF1 in the
2<sup>nd</sup> week after HF / <break/> &#x02193;HSP72 and
&#x02193;HSF1 after heat exposure with disease progression</td></tr><tr><td align="left" rowspan="1" colspan="1">McGinley et al.<sup>[</sup><sup><xref rid="r35" ref-type="bibr">35</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of exogenous HSP27 on
mesenchymal stem cell therapy in the heart</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 &#x02191;the survival of cell
therapy <italic>in vitro</italic> and <italic>in vivo</italic> /
&#x02191;HSP27 &#x02193;apoptosis and &#x02191;cardiac
function</td></tr><tr><td align="left" rowspan="1" colspan="1">Meldrum et al.<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the effect of liposomal delivery of
HSP70 and the role in cardioprotection</td><td align="center" rowspan="1" colspan="1">Intracoronary perfusion of the liposomal
protein<break/>&#x02191;HSP70 in the myocardium / &#x02191;HSP70
prevents LPS-induced dysfunction</td></tr><tr><td align="left" rowspan="1" colspan="1">Moalic et al.<sup>[</sup><sup><xref rid="r38" ref-type="bibr">38</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To verify the involvement of circulating hormones
in HSP70 expression</td><td align="center" rowspan="1" colspan="1">Heat stress &#x02191;HSP70 / Phenylephrine and
vasopressin <break/>&#x02191;HSP70, but angiotensin II did
not</td></tr><tr><td align="left" rowspan="1" colspan="1">Niizeki et al.<sup>[</sup><sup><xref rid="r69" ref-type="bibr">69</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine whether HSP 60 is correlated with the
severity of CHF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 in patients with CHF to the control
group / <break/>&#x02191;HSP60 was associated with functional
classification of CHF and risk of adverse events</td></tr><tr><td align="left" rowspan="1" colspan="1">Nomura et al.<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the role of HSP70 in the recovery
of hypothermic cardioplegic ischemia</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 expression in 15 min after heat
stress (43&#x000b0;) and persisted up to 24h / &#x02191;HSP70 improved
the recovery of systolic and coronary endothelial function</td></tr><tr><td align="left" rowspan="1" colspan="1">Okubo et al.<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To observe the effect of the overexpression of
HSP70 in myocardial protection</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 &#x02193;myocardial infarct size /
&#x02191;HSP70 &#x02193;the severity of ischemic injury</td></tr><tr><td align="left" rowspan="1" colspan="1">Ooie et al.<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the role of geranylgeranyl acetone
(GGA) in HSP expression in cardioprotection</td><td align="center" rowspan="1" colspan="1">Treatment &#x02191;HSP70 dose-dependent manner
with peak expression at 24 hours after administration /
&#x02191;HSP72 provides cardioprotection by ischemia/reperfusion
and &#x02191;post-ischemic recovery</td></tr><tr><td align="left" rowspan="1" colspan="1">Osaki et al.<sup>[</sup><sup><xref rid="r44" ref-type="bibr">44</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the involvement of protein kinase A
and protein kinase C in pressure-induced HSP70 expression</td><td align="center" rowspan="1" colspan="1">Elevation of aortic pressure &#x02191;HSP70 /
&#x02191;HSP70 are regulated both by PKA and PKC-dependent
systems</td></tr><tr><td align="left" rowspan="1" colspan="1">Qian et al.<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the ischemic preconditioning
cardioprotection and to correlate with HSP70 expression</td><td align="center" rowspan="1" colspan="1">Heat stress and preconditioning &#x02191;HPS70 /
heat stress <break/> &#x02193;infarct size</td></tr><tr><td align="left" rowspan="1" colspan="1">Qiu et al.<sup>[</sup><sup><xref rid="r73" ref-type="bibr">73</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the function of HSP22 in cardiac
overload pressure</td><td align="center" rowspan="1" colspan="1">HSP22 deletion accelerates transition to HF in
the context of cardiac overload pressure</td></tr><tr><td align="left" rowspan="1" colspan="1">Rahsepar et al.<sup>[</sup><sup><xref rid="r72" ref-type="bibr">72</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To analyze the levels of HSP27 in patients with
valvular heart disease</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 in patients with valvular heart
disease / <break/>&#x02191;HSP27 may be useful as a biomarker in
the assessment of HF</td></tr><tr><td align="left" rowspan="1" colspan="1">Raju et al.<sup>[</sup><sup><xref rid="r45" ref-type="bibr">45</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the regulation of HSP32 in the
right-sided congestive heart failure model</td><td align="center" rowspan="1" colspan="1">Congestive heart failure &#x02191;HSP32, but
&#x02194;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Rinaldi et al.<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To observe the effects of age and exercise on the
antioxidant system and expression of HSP27 and HSP70</td><td align="center" rowspan="1" colspan="1">Physical exercise &#x02191;HSP27 and &#x02191;HSP70
/ &#x02191;HSP27 and <break/>&#x02191;HSP70 &#x02193;the
deleterious effect of age on the antioxidant system of the
heart</td></tr><tr><td align="left" rowspan="1" colspan="1">Rothenbacher et al.<sup>[</sup><sup><xref rid="r63" ref-type="bibr">63</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate whether HSP60 is associated with
heart disease</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 does not seem to be an independent
risk factor for coronary artery disease</td></tr><tr><td align="left" rowspan="1" colspan="1">Satoh et al.<sup>[</sup><sup><xref rid="r66" ref-type="bibr">66</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the relationship between blood HSP70
and TLR4 after myocardial infarction</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 in patients than controls /
&#x02191;HSP70 and <break/> &#x02191;cytokines mediated TLR4
receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">Schmitt et al.<sup>[</sup><sup><xref rid="r48" ref-type="bibr">48</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the synthesis of HSP70 in the
human heart <italic>in vivo</italic> after CABG</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 occurred after at least 2 hours of
stress induction by CABG </td></tr><tr><td align="left" rowspan="1" colspan="1">Shinohara et al.<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To observe the effect of estrogen on the
expression of HSP72 after ischemic damage</td><td align="center" rowspan="1" colspan="1">Estrogen &#x02193;HSP72 induced by hyperthermia
/&#x02191;HSP72 promotes ischemic protection</td></tr><tr><td align="left" rowspan="1" colspan="1">Staib et al.<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of heat stress and
mechanical overload on the HSP70 expression</td><td align="center" rowspan="1" colspan="1">Hyperthermia, regardless of workload, resulted in
significant &#x02191;HSP70 in the heart</td></tr><tr><td align="left" rowspan="1" colspan="1">Tanonaka et al.<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To evaluate the HSP72 production level during CHF
and its relation to cardiac protection</td><td align="center" rowspan="1" colspan="1">Hyperthermia &#x02191;HSP72 in the 2<sup>nd</sup>
week, but not in the 8<sup>th</sup> week / &#x02191;HSP72 was
inversely correlated with worsening of the cardiac parameters /
Advanced HF <break/> &#x02193;HSP72</td></tr><tr><td align="left" rowspan="1" colspan="1">Tanonaka et al.<sup>[</sup><sup><xref rid="r43" ref-type="bibr">43</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To verify the expression of HSP during the
development of HF</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP27 and &#x02191;HSP70 in the
1<sup>st</sup> week, but not in the 8<sup>th</sup> week /
There was &#x02191;HSP60 only in the 8<sup>th</sup> week </td></tr><tr><td align="left" rowspan="1" colspan="1">Tanonaka et al.<sup>[</sup><sup><xref rid="r39" ref-type="bibr">39</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the HSP72 expression in HF after acute
myocardial infarction</td><td align="center" rowspan="1" colspan="1">The development of HF &#x02193;HSP70 by
hyperthermia</td></tr><tr><td align="left" rowspan="1" colspan="1">Ugurlucan et al.<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of diabetes mellitus
and glutamine administration on HSP70 expression in the
heart</td><td align="center" rowspan="1" colspan="1">Diabetes &#x02191;HSP70 in the myocardium /
Parenteral administration of glutamine &#x02191;HSP70</td></tr><tr><td align="left" rowspan="1" colspan="1">Veres et al.<sup>[</sup><sup><xref rid="r64" ref-type="bibr">64</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To explore the relationship between familial risk
for heart disease and HSP60</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 in the group with high familial
risk / Children with &#x02191;HSP60 showed higher values of
<italic>odds ratio</italic> for heart disease /
&#x02191;HSP60 can be considered a relative risk factor for heart
disease</td></tr><tr><td align="left" rowspan="1" colspan="1">Vittorini et al.<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To assess the HSP70 gene expression during blood
cardioplegic arrest in children</td><td align="center" rowspan="1" colspan="1">Blood cardioplegia &#x02191;HSP70 and protection
of the ischemia/reperfusion injury</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang et al.<sup>[</sup><sup><xref rid="r46" ref-type="bibr">46</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the regulation and transcription
of HSP60 and HSP72 in HF</td><td align="center" rowspan="1" colspan="1">There were &#x02191;HSP60 and hNF kB in HF /
&#x02191;HSP60 may be mediated by hNFkB / &#x02194;HSP70 because &#x02194;HSF1 in
HF</td></tr><tr><td align="left" rowspan="1" colspan="1">Wei et al.<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To observe protein changes in hearts with HF and
to identify potential biomarkers of this condition</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP70 is the common feature of HF /
&#x02191;HSP70 may be used as a biomarker for the presence of HF
and may hold diagnostic/prognostic potential in clinical
practice</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et al.<sup>[</sup><sup><xref rid="r36" ref-type="bibr">36</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To compare HSP expression in patients with and
without atrial fibrillation</td><td align="center" rowspan="1" colspan="1">&#x02193;HSP27 in patients with atrial
fibrillation</td></tr><tr><td align="left" rowspan="1" colspan="1">Xi et al.<sup>[</sup><sup><xref rid="r37" ref-type="bibr">37</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigue whether the whole-body heat stress
induces HSP70 expression and offers cardioprotection</td><td align="center" rowspan="1" colspan="1">Whole-body heat stress &#x02191;HSP70 / No
differences in HSP70 or control groups in infarct size after
ischemia/reperfusion</td></tr><tr><td align="left" rowspan="1" colspan="1">Yamanaka et al.<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the effect of treatment with
geranylgeranyl acetone (GGA) in the expression of HSP72</td><td align="center" rowspan="1" colspan="1">Treatment with GGA &#x02191;HSP72 and
&#x02191;HSF-1 / &#x02191;the recovery after ischemia/reperfusion
/ &#x02191;HSP72 promoted cardioprotection</td></tr><tr><td align="left" rowspan="1" colspan="1">Yamashita et al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To compare the time course of tolerance to
myocardial injury with the time course of HSP70 induction</td><td align="center" rowspan="1" colspan="1">&#x02193;infarct size in 48 and 72 hours after
heat stress / &#x02191;HSP70 content correlates with time course
of cardioprotection</td></tr><tr><td align="left" rowspan="1" colspan="1">Yan et al.<sup>[</sup><sup><xref rid="r55" ref-type="bibr">55</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To investigate the expression of HSP60 in the
heart, liver, and kidney of stressed broilers</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 is specific and can be related to
tissue damage in response to thermal stress / In the heart
&#x02191;HSP60 peaked at 5h after stress</td></tr><tr><td align="left" rowspan="1" colspan="1">Yu et al.<sup>[</sup><sup><xref rid="r54" ref-type="bibr">54</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine the HSP70 expression in cardiac and
renal tissues of transport-stressed pigs</td><td align="center" rowspan="1" colspan="1">Transport stress &#x02191;HSP70 in cardiac and
renal tissues</td></tr><tr><td align="left" rowspan="1" colspan="1">Yu et al.<sup>[</sup><sup><xref rid="r50" ref-type="bibr">50</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the expression of HSP70 after several
periods of ischemia/reperfusion</td><td align="center" rowspan="1" colspan="1">Permanent ischemia and ischemia/reperfusion
&#x02191;HSP70 / &#x02191;HSP70 from 30 min to 24h after
ischemia/reperfusion</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhang et al.<sup>[</sup><sup><xref rid="r70" ref-type="bibr">70</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To observe the correlation of HSP60 and CHD</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 is related to the risk of CHD</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhang et al.<sup>[</sup><sup><xref rid="r71" ref-type="bibr">71</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To determine whether HSP60, hypertension and
diabetes have joint effects on CHD risk</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP60 in the group with CHD than controls
/ &#x02191;HSP60 is positively correlated with the risk and
severity of CHD</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhao et al.<sup>[</sup><sup><xref rid="r32" ref-type="bibr">32</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To examine the effects of probiotics-derived
protein on heart injury</td><td align="center" rowspan="1" colspan="1">Probiotics-derived protein &#x02191;HSP70 in heart
cells and <break/> &#x02193;&#x000a0;damage of ischemia/reperfusion</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhong et al.<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To quantify the HSP70 levels hypoxia-induced and
its relation to cardioprotection</td><td align="center" rowspan="1" colspan="1">Hypoxia &#x02191;HSP70 and it provides protection
against ischemia/reperfusion / &#x02191;HSP70 can stay up to two
weeks after hypoxia</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhu and Wang<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup></td><td align="center" rowspan="1" colspan="1">To explore whether overexpression of HSP20 in
cardiomyocytes protects against injury</td><td align="center" rowspan="1" colspan="1">&#x02191;HSP20 &#x02193;the necrotic and
&#x02193;apoptotic cardiomyocytes</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>&#x02191;=increase; &#x02193;=decrease; &#x02194; =no changes; CABG=coronary
artery bypass grafting; CHD=coronary heart disease; CHF=chronic
heart failure; CK=creatine kinase; HF=heart failure;
ICH=intracerebral hemorrhage</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In summary, the literature provides consistent evidence that HSP20, HSP25, HSP27,
HSP32 and HSP70 promote a protective effect following heart damage. Overexpression
of these proteins in cardiac tissue increases protection as a natural result of
ischemic damage, decreases infarcted area and myocardial apoptosis, and aids in
heart recovery.</p><p>The increase in expression of these proteins can occur through some systemic
stresses, such as hyper- and hypothermia, hypoxia, physical exercise and
cardioplegia, as well as some substances and treatments, or the stress produced by
heart disease. The sum of these findings could be useful under conditions in which
it is necessary to induce ischemic damage, as in the case of surgery with
cardiopulmonary bypass or other surgical procedures that include the temporary
cutoff of supplies to the heart, in addition to improving cardiovascular endurance
through heart disease. However, studies and procedures in human subjects still need
to be more widely studied.</p><p>Although limited, knowledge on the role of HSPs as possible biomarkers has shown that
HSP20, HSP27, HSP60 and HSP70 correlate well with heart disease, disease severity
and resulting adverse events, the use of these proteins in the myocardium or in the
blood is currently under evaluation as predictive markers in pre- and post-surgery.
Little or no reference has been found in the literature, however, about the
possibility of manipulating the production of these repair proteins. However, a
likely practical application for the use of HSPs could be available if we could
either enhance the overexpression by specific diet or avoid the use of practices or
therapeutic procedures that could jeopardize the expression of HSPs and their
benefits. While our understanding of these major HSPs in heart disease is
incomplete, there is a clear potential role for the therapeutic modulation of HSPs
in the practical clinical context. In the absence of such data, further studies
would be required to better explore this natural repair system, perhaps even as a
tool to evaluate the success of the therapy.</p><table-wrap id="t3" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VASJ</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PCBL</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CSM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JAF</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PNM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Faculdade Faculdade de Engenharia de Alimentos
(FEA) da Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kampinga</surname><given-names>HH</given-names></name><name><surname>Hageman</surname><given-names>J</given-names></name><name><surname>Vos</surname><given-names>MJ</given-names></name><name><surname>Kubota</surname><given-names>H</given-names></name><name><surname>Tanquay</surname><given-names>RM</given-names></name><name><surname>Bruford</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Guidelines for the nomenclature of the human heat shock
proteins</article-title><source>Cell Stress Chaperones</source><year>2009</year><volume>14</volume><issue>1</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">18663603</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name></person-group><article-title>Role of the heat shock response and molecular chaperones in
oncogenesis and cell death</article-title><source>J Natl Cancer Inst</source><year>2000</year><volume>92</volume><issue>19</issue><fpage>1564</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">11018092</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>BH</given-names></name><name><surname>Jiang</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>JZ</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Vogt</surname><given-names>PK</given-names></name></person-group><article-title>Phosphatidylinositol 3-kinase signaling controls levels of
hypoxia-inducible factor 1</article-title><source>Cell Growth Differ</source><year>2001</year><volume>12</volume><issue>7</issue><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">11457733</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beere</surname><given-names>HM</given-names></name></person-group><article-title>Death versus survival: functional interaction between the
apoptotic and stress-inducible heat shock protein pathways</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><issue>10</issue><fpage>2633</fpage><lpage>2639</lpage><pub-id pub-id-type="pmid">16200196</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanonaka</surname><given-names>K</given-names></name><name><surname>Furuhama</surname><given-names>KI</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Kakuta</surname><given-names>K</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Toga</surname><given-names>W</given-names></name><etal/></person-group><article-title>Protective effect of heat shock protein 72 on contractile
function of perfused failing heart</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>281</volume><issue>1</issue><fpage>H215</fpage><lpage>H222</lpage><pub-id pub-id-type="pmid">11406488</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staib</surname><given-names>JL</given-names></name><name><surname>Quindry</surname><given-names>JC</given-names></name><name><surname>French</surname><given-names>JP</given-names></name><name><surname>Criswell</surname><given-names>DS</given-names></name><name><surname>Powers</surname><given-names>SK</given-names></name></person-group><article-title>Increased temperature, not cardiac load, activates heat shock
transcription factor 1 and heat shock protein 72 expression in the
heart</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>292</volume><issue>1</issue><fpage>R432</fpage><lpage>R439</lpage><pub-id pub-id-type="pmid">16990482</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marunouchi</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>N</given-names></name><name><surname>Tanonaka</surname><given-names>K</given-names></name></person-group><article-title>Possible involvement of phosphorylated heat-shock factor-1 in
changes in heat shock protein 72 induction in the failing rat heart
following myocardial infarction</article-title><source>Biol Pharm Bull</source><year>2013</year><volume>36</volume><issue>8</issue><fpage>1332</fpage><lpage>1340</lpage><pub-id pub-id-type="pmid">23902977</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>B</given-names></name><name><surname>Corbi</surname><given-names>G</given-names></name><name><surname>Boccuti</surname><given-names>S</given-names></name><name><surname>Filippelli</surname><given-names>W</given-names></name><name><surname>Rengo</surname><given-names>G</given-names></name><name><surname>Leosco</surname><given-names>D</given-names></name><etal/></person-group><article-title>Exercise training affects age-induced changes in SOD and heat
shock protein expression in rat heart</article-title><source>Exp Gerontol</source><year>2006</year><volume>41</volume><issue>8</issue><fpage>764</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">16822632</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Ooie</surname><given-names>T</given-names></name><name><surname>Kaneda</surname><given-names>K</given-names></name><name><surname>Yoshimatsu</surname><given-names>H</given-names></name><name><surname>Saikawa</surname><given-names>T</given-names></name></person-group><article-title>Role of protein kinase C in geranylgeranylacetone-induced
expression of heat-shock protein 72 and cardioprotection in the rat
heart</article-title><source>J Mol Cell Cardiol</source><year>2003</year><volume>35</volume><issue>7</issue><fpage>785</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">12818569</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugurlucan</surname><given-names>M</given-names></name><name><surname>Erer</surname><given-names>D</given-names></name><name><surname>Karatepe</surname><given-names>O</given-names></name><name><surname>Ziyade</surname><given-names>S</given-names></name><name><surname>Haholu</surname><given-names>A</given-names></name><name><surname>Gungor Ugurlucan</surname><given-names>F</given-names></name><etal/></person-group><article-title>Glutamine enhances the heat shock protein 70 expression as a
cardioprotective mechanism in left heart tissues in the presence of diabetes
mellitus</article-title><source>Expert Opin Ther Targets</source><year>2010</year><volume>14</volume><issue>11</issue><fpage>1143</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">20942745</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>QZ</given-names></name><name><surname>Zhou</surname><given-names>ZN</given-names></name></person-group><article-title>Intermittent hypoxia exposure-induced heat-shock protein 70
expression increases resistance of rat heart to ischemic
injury</article-title><source>Acta Pharmacol Sin</source><year>200</year><volume>21</volume><issue>5</issue><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">11324449</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>S</given-names></name><name><surname>Wildner</surname><given-names>O</given-names></name><name><surname>Shah</surname><given-names>MR</given-names></name><name><surname>Chelliah</surname><given-names>JC</given-names></name><name><surname>Hess</surname><given-names>ML</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><article-title>Gene transfer of heat-shock protein 70 reduces infarct size in
vivo after ischemia/reperfusion in the rabbit heart</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>6</issue><fpage>877</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">11171798</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kang</surname><given-names>SM</given-names></name><name><surname>Chung</surname><given-names>N</given-names></name><name><surname>Jang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Protective effect of heat shock protein 27 using protein
transduction domain-mediated delivery on ischemia/reperfusion heart
injury</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>363</volume><issue>2</issue><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">17869218</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vittorini</surname><given-names>S</given-names></name><name><surname>Storti</surname><given-names>S</given-names></name><name><surname>Andreani</surname><given-names>G</given-names></name><name><surname>Giusti</surname><given-names>L</given-names></name><name><surname>Murzi</surname><given-names>B</given-names></name><name><surname>Furfori</surname><given-names>P</given-names></name><etal/></person-group><article-title>Heat shock protein 70-1 gene expression in pediatric heart
surgery using blood cardioplegia</article-title><source>Clin Chem Lab Med</source><year>2007</year><volume>45</volume><issue>2</issue><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">17311516</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>YJ</given-names></name><name><surname>Huang</surname><given-names>YX</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Proteomic analysis reveals significant elevation of heat shock
protein 70 in patients with chronic heart failure due to arrhythmogenic
right ventricular cardiomyopathy</article-title><source>Mol Cell Biochem</source><year>2009</year><volume>332</volume><issue>1-2</issue><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">19543852</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonanad</surname><given-names>C</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>J</given-names></name><name><surname>Sanchis</surname><given-names>J</given-names></name><name><surname>Bodi</surname><given-names>V</given-names></name><name><surname>Chaustre</surname><given-names>F</given-names></name><name><surname>Chillet</surname><given-names>M</given-names></name><etal/></person-group><article-title>Serum heat shock protein 60 in acute heart failure: a new
biomarker?</article-title><source>Congest Heart Fail</source><year>2013</year><volume>19</volume><issue>1</issue><fpage>6</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">22702715</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Heat shock protein 70 acts as a potential biomarker for early
diagnosis of heart failure</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>7</issue><elocation-id>e67964</elocation-id><pub-id pub-id-type="pmid">23874478</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Hoshida</surname><given-names>S</given-names></name><name><surname>Nishida</surname><given-names>M</given-names></name><name><surname>Igarashi</surname><given-names>J</given-names></name><name><surname>Aoki</surname><given-names>K</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><etal/></person-group><article-title>Time course of tolerance to ischemia-reperfusion injury and
induction of heat shock protein 72 by heat stress in the rat
heart</article-title><source>J Mol Cell Cardiol</source><year>1997</year><volume>29</volume><issue>7</issue><fpage>1815</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">9236136</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>RC</given-names></name><name><surname>Qian</surname><given-names>YZ</given-names></name><name><surname>Okubo</surname><given-names>S</given-names></name><name><surname>Flaherty</surname><given-names>EE</given-names></name></person-group><article-title>Role of protein kinase C and 72 kDa heat shock protein in
ischemic tolerance following heat stress in the rat heart</article-title><source>Mol Cell Biochem</source><year>1999</year><volume>195</volume><issue>1-2</issue><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">10395076</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>YZ</given-names></name><name><surname>Bernardo</surname><given-names>NL</given-names></name><name><surname>Nayeem</surname><given-names>MA</given-names></name><name><surname>Chelliah</surname><given-names>J</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><article-title>Induction of 72-kDa heat shock protein does not produce second
window of ischemic preconditioning in rat heart</article-title><source>Am J Physiol</source><year>1999</year><volume>276</volume><issue>1</issue><issue-part>Pt 2</issue-part><fpage>H224</fpage><lpage>H234</lpage><pub-id pub-id-type="pmid">9887036</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meldrum</surname><given-names>DR</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Shames</surname><given-names>BD</given-names></name><name><surname>Pomerantz</surname><given-names>B</given-names></name><name><surname>Donnahoo</surname><given-names>KK</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><etal/></person-group><article-title>Liposomal delivery of heat-shock protein 72 into the heart
prevents endotoxin-induced myocardial contractile
dysfunction</article-title><source>Surgery</source><year>1999</year><volume>126</volume><issue>2</issue><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">10455875</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>F</given-names></name><name><surname>Aoki</surname><given-names>M</given-names></name><name><surname>Forbess</surname><given-names>JM</given-names></name><name><surname>Mayer Jr</surname><given-names>JE</given-names></name></person-group><article-title>Myocardial self-preservative effect of heat shock protein 70 on
an immature lamb heart</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>68</volume><issue>5</issue><fpage>1736</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">10585051</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SO</given-names></name><name><surname>Baines</surname><given-names>CP</given-names></name><name><surname>Critz</surname><given-names>SD</given-names></name><name><surname>Pelech</surname><given-names>SL</given-names></name><name><surname>Katz</surname><given-names>S</given-names></name><name><surname>Downey</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Ischemia induced activation of heat shock protein 27 kinases and
casein kinase 2 in the preconditioned rabbit heart</article-title><source>Biochem Cell Biol</source><year>1999</year><volume>77</volume><issue>6</issue><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">10668633</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooie</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Saikawa</surname><given-names>T</given-names></name><name><surname>Nawata</surname><given-names>T</given-names></name><name><surname>Arikawa</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><etal/></person-group><article-title>Single oral dose of geranylgeranylacetone induces heat-shock
protein 72 and renders protection against ischemia/reperfusion injury in rat
heart</article-title><source>Circulation</source><year>2001</year><volume>104</volume><issue>15</issue><fpage>1837</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">11591623</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efthymiou</surname><given-names>CA</given-names></name><name><surname>Mocanu</surname><given-names>MM</given-names></name><name><surname>Belleroche</surname><given-names>J</given-names></name><name><surname>Wells</surname><given-names>DJ</given-names></name><name><surname>Latchmann</surname><given-names>DS</given-names></name><name><surname>Yellon</surname><given-names>DM</given-names></name></person-group><article-title>Heat shock protein 27 protects the heart against myocardial
infarction</article-title><source>Basic Res Cardiol</source><year>2004</year><volume>99</volume><issue>6</issue><fpage>392</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">15309411</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinohara</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Ooie</surname><given-names>T</given-names></name><name><surname>Ichinose</surname><given-names>M</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Yonemochi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Estrogen inhibits hyperthermia-induced expression of heat-shock
protein 72 and cardioprotection against ischemia/reperfusion injury in
female rat heart</article-title><source>J Mol Cell Cardiol</source><year>2004</year><volume>37</volume><issue>5</issue><fpage>1053</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">15522282</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>XJ</given-names></name><name><surname>Lu</surname><given-names>XY</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>LP</given-names></name><name><surname>Yang</surname><given-names>HT</given-names></name><etal/></person-group><article-title>Phosphorylated heat shock protein 27 is involved in enhanced
heart tolerance to ischemia in short-term type 1 diabetic
rats</article-title><source>Acta Pharmacol Sin</source><year>2005</year><volume>26</volume><issue>7</issue><fpage>806</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">15960886</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthaman</surname><given-names>K</given-names></name><name><surname>Banerjee</surname><given-names>SK</given-names></name><name><surname>Dinda</surname><given-names>AK</given-names></name><name><surname>Ghosh</surname><given-names>CC</given-names></name><name><surname>Maulik</surname><given-names>SK</given-names></name></person-group><article-title>Terminalia arjuna (Roxb.) protects rabbit heart against
ischemic-reperfusion injury: role of antioxidant enzymes and heat shock
protein</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>96</volume><issue>3</issue><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">15619558</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Overexpression of heat-shock protein 20 in rat heart myogenic
cells confers protection against simulated ischemia/reperfusion
injury</article-title><source>Acta Pharmacol Sin</source><year>2005</year><volume>26</volume><issue>9</issue><fpage>1076</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">16115374</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Shinohara</surname><given-names>T</given-names></name><name><surname>Ooie</surname><given-names>T</given-names></name><name><surname>Yufu</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Receptor-mediated suppression of cardiac heat-shock protein 72
expression by testosterone in male rat heart</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><issue>7</issue><fpage>3148</fpage><lpage>3155</lpage><pub-id pub-id-type="pmid">17395695</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>K</given-names></name><name><surname>Kanagasabai</surname><given-names>R</given-names></name><name><surname>Druhan</surname><given-names>LJ</given-names></name><name><surname>Ilangovan</surname><given-names>G</given-names></name></person-group><article-title>Heat shock protein 25-enriched plasma transfusion preconditions
the heart against doxorubicin-induced dilated cardiomyopathy in
mice</article-title><source>J Pharmacol Exp Ther</source><year>2012</year><volume>341</volume><issue>3</issue><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">22438470</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Carboxy terminus of heat shock protein (HSP) 70-interacting
protein (CHIP) inhibits HSP70 in the heart</article-title><source>J Physiol Biochem</source><year>2012</year><volume>68</volume><issue>4</issue><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">22456997</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lv</surname><given-names>C</given-names></name><etal/></person-group><article-title>Nucleolin protects the heart from ischaemia-reperfusion injury by
up-regulating heat shock protein 32</article-title><source>Cardiovasc Res</source><year>2013</year><volume>99</volume><issue>1</issue><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">23594402</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><article-title>Anandamide enhances expression of heat shock protein 72 to
protect against ischemia-reperfusion injury in rat heart</article-title><source>J Physiol Sci</source><year>2013</year><volume>63</volume><issue>1</issue><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">23007622</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinley</surname><given-names>LM</given-names></name><name><surname>McMahon</surname><given-names>J</given-names></name><name><surname>Stocca</surname><given-names>A</given-names></name><name><surname>Duffy</surname><given-names>A</given-names></name><name><surname>Flynn</surname><given-names>A</given-names></name><name><surname>O'Toole</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mesenchymal stem cell survival in the infarcted heart is enhanced
by lentivirus vector-mediated heat shock protein 27
expression</article-title><source>Hum Gene Ther</source><year>2013</year><volume>24</volume><issue>10</issue><fpage>840</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">23987185</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Decreased Cardiac Expression of Heat Shock Protein 27 is
Associated with Atrial Fibrillation in Patients with Rheumatic Heart
Disease</article-title><source>Acta Cardiol Sin</source><year>2015</year><volume>31</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">27122840</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Chelliah</surname><given-names>J</given-names></name><name><surname>Nayeem</surname><given-names>MA</given-names></name><name><surname>Levasseur</surname><given-names>JE</given-names></name><name><surname>Hess</surname><given-names>ML</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><article-title>Whole body heat shock fails to protect mouse heart against
ischemia/reperfusion injury: role of 72 kDa heat shock protein and
antioxidant enzymes</article-title><source>J Mol Cell Cardiol</source><year>1998</year><volume>30</volume><issue>11</issue><fpage>2213</fpage><lpage>2227</lpage><pub-id pub-id-type="pmid">9925359</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moalic</surname><given-names>JM</given-names></name><name><surname>Bauters</surname><given-names>C</given-names></name><name><surname>Himbert</surname><given-names>D</given-names></name><name><surname>Bercovici</surname><given-names>J</given-names></name><name><surname>Mouas</surname><given-names>C</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><etal/></person-group><article-title>Phenylephrine, vasopressin and angiotensin II as determinants of
proto-oncogene and heat-shock protein gene expression in adult rat heart and
aorta</article-title><source>J Hypertens</source><year>1989</year><volume>7</volume><issue>3</issue><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">2708815</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanonaka</surname><given-names>K</given-names></name><name><surname>Toga</surname><given-names>W</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Oikawa</surname><given-names>R</given-names></name><name><surname>Takeo</surname><given-names>S</given-names></name></person-group><article-title>Induction of heat shock protein 72 in the failing heart is
attenuated after an exposure to heat shock</article-title><source>Mol Cell Biochem</source><year>2004</year><volume>259</volume><issue>1-2</issue><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">15124926</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>RC</given-names></name><name><surname>Kontos</surname><given-names>MC</given-names></name><name><surname>Loesser</surname><given-names>KE</given-names></name><name><surname>Batra</surname><given-names>SK</given-names></name><name><surname>Qian</surname><given-names>YZ</given-names></name><name><surname>Gbur Jr</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Oxidant stress increases heat shock protein 70 mRNA in isolated
perfused rat heart</article-title><source>Am J Physiol</source><year>1994</year><volume>267</volume><issue>6</issue><issue-part>Pt 2</issue-part><fpage>H2213</fpage><lpage>H2219</lpage><pub-id pub-id-type="pmid">7810720</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>R</given-names></name><name><surname>Bongrazio</surname><given-names>M</given-names></name><name><surname>Cargnoni</surname><given-names>A</given-names></name><name><surname>Comini</surname><given-names>L</given-names></name><name><surname>Pasini</surname><given-names>E</given-names></name><name><surname>Gaia</surname><given-names>G</given-names></name><etal/></person-group><article-title>Heat shock protein changes in hibernation: a similarity with
heart failure?</article-title><source>J Mol Cell Cardiol</source><year>1996</year><volume>28</volume><issue>12</issue><fpage>2383</fpage><lpage>2395</lpage><pub-id pub-id-type="pmid">9004155</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comini</surname><given-names>L</given-names></name><name><surname>Gaia</surname><given-names>G</given-names></name><name><surname>Curello</surname><given-names>S</given-names></name><name><surname>Ceconi</surname><given-names>C</given-names></name><name><surname>Pasini</surname><given-names>E</given-names></name><name><surname>Benigno</surname><given-names>M</given-names></name><etal/></person-group><article-title>Right heart failure chronically stimulates heat shock protein 72
in heart and liver but not in other tissues</article-title><source>Cardiovasc Res</source><year>1996</year><volume>31</volume><issue>6</issue><fpage>882</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">8759243</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanonaka</surname><given-names>K</given-names></name><name><surname>Toga</surname><given-names>W</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Takeo</surname><given-names>S</given-names></name></person-group><article-title>Myocardial heat shock protein changes in the failing heart
following coronary artery ligation</article-title><source>Heart Lung Circ</source><year>2003</year><volume>12</volume><issue>1</issue><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16352108</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaki</surname><given-names>J</given-names></name><name><surname>Haneda</surname><given-names>T</given-names></name><name><surname>Kashiwagi</surname><given-names>Y</given-names></name><name><surname>Oi</surname><given-names>S</given-names></name><name><surname>Fukuzawa</surname><given-names>J</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Pressure-induced expression of heat shock protein 70 mRNA in
adult rat heart is coupled both to protein kinase A-dependent and protein
kinase C-dependent systems</article-title><source>J Hypertens</source><year>1998</year><volume>16</volume><issue>8</issue><fpage>1193</fpage><lpage>1200</lpage><pub-id pub-id-type="pmid">9794724</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>VS</given-names></name><name><surname>Imai</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>CS</given-names></name></person-group><article-title>Chamber-specific regulation of heme oxygenase-1 (heat shock
protein 32) in right-sided congestive heart failure</article-title><source>J Mol Cell Cardiol</source><year>1999</year><volume>31</volume><issue>8</issue><fpage>1581</fpage><lpage>1589</lpage><pub-id pub-id-type="pmid">10423355</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hagiwara</surname><given-names>N</given-names></name><name><surname>Knowlton</surname><given-names>AA</given-names></name></person-group><article-title>Regulation of heat shock protein 60 and 72 expression in the
failing heart</article-title><source>J Mol Cell Cardiol</source><year>2010</year><volume>48</volume><issue>2</issue><fpage>360</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">19945465</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowlton</surname><given-names>AA</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>Heat-shock factor-1, steroid hormones, and regulation of
heat-shock protein expression in the heart</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><issue>1</issue><fpage>H455</fpage><lpage>H464</lpage><pub-id pub-id-type="pmid">11123263</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>JP</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Birnbaum</surname><given-names>DE</given-names></name><name><surname>Aebert</surname><given-names>H</given-names></name></person-group><article-title>Kinetics of heat shock protein 70 synthesis in the human heart
after cold cardioplegic arrest</article-title><source>Eur J Cardiothorac Surg</source><year>2002</year><volume>22</volume><issue>3</issue><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">12204733</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dybdahl</surname><given-names>B</given-names></name><name><surname>Wahba</surname><given-names>A</given-names></name><name><surname>Lien</surname><given-names>E</given-names></name><name><surname>Flo</surname><given-names>TH</given-names></name><name><surname>Waage</surname><given-names>A</given-names></name><name><surname>Qureshi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Inflammatory response after open heart surgery: release of
heat-shock protein 70 and signaling through toll-like
receptor-4</article-title><source>Circulation</source><year>2002</year><volume>105</volume><issue>6</issue><fpage>685</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">11839622</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name><name><surname>Asano</surname><given-names>G</given-names></name></person-group><article-title>Time course of expression and localization of heat shock protein
72 in the ischemic and reperfused rat heart</article-title><source>Jpn Circ J</source><year>1999</year><volume>63</volume><issue>4</issue><fpage>278</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">10475776</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>CC</given-names></name><name><surname>Amrani</surname><given-names>M</given-names></name><name><surname>Smolenski</surname><given-names>RT</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name></person-group><article-title>Cold cardioplegic arrest enhances heat shock protein 70 in the
heat-shocked rat heart</article-title><source>J Thorac Cardiovasc Surg</source><year>2001</year><volume>121</volume><issue>6</issue><fpage>1130</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">11385380</pub-id></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayose</surname><given-names>D</given-names></name><name><surname>Isoyama</surname><given-names>S</given-names></name><name><surname>Fujita</surname><given-names>H</given-names></name><name><surname>Shibahara</surname><given-names>S</given-names></name></person-group><article-title>Separate regulation of heme oxygenase and heat shock protein 70
mRNA expression in the rat heart by hemodynamic stress</article-title><source>Biochem Biophys Res Commun</source><year>1993</year><volume>191</volume><issue>2</issue><fpage>587</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">8461015</pub-id></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowlton</surname><given-names>AA</given-names></name><name><surname>Eberli</surname><given-names>FR</given-names></name><name><surname>Brecher</surname><given-names>P</given-names></name><name><surname>Romo</surname><given-names>GM</given-names></name><name><surname>Owen</surname><given-names>A</given-names></name><name><surname>Apstein</surname><given-names>CS</given-names></name></person-group><article-title>A single myocardial stretch or decreased systolic fiber
shortening stimulates the expression of heat shock protein 70 in the
isolated, erythrocyte-perfused rabbit heart</article-title><source>J Clin Invest</source><year>1991</year><volume>88</volume><issue>6</issue><fpage>2018</fpage><lpage>2025</lpage><pub-id pub-id-type="pmid">1752959</pub-id></element-citation></ref><ref id="r54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Bao</surname><given-names>ED</given-names></name><name><surname>Zhao</surname><given-names>RQ</given-names></name><name><surname>Lv</surname><given-names>QX</given-names></name></person-group><article-title>Effect of transportation stress on heat shock protein 70
concentration and mRNA expression in heart and kidney tissues and serum
enzyme activities and hormone concentrations of pigs</article-title><source>Am J Vet Res</source><year>2007</year><volume>68</volume><issue>11</issue><fpage>1145</fpage><lpage>1150</lpage><pub-id pub-id-type="pmid">17975967</pub-id></element-citation></ref><ref id="r55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Heat shock protein 60 expression in heart, liver and kidney of
broilers exposed to high temperature</article-title><source>Res Vet Sci</source><year>2009</year><volume>86</volume><issue>3</issue><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">18951595</pub-id></element-citation></ref><ref id="r56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppichler</surname><given-names>F</given-names></name><name><surname>Lechleitner</surname><given-names>M</given-names></name><name><surname>Traweger</surname><given-names>C</given-names></name><name><surname>Schett</surname><given-names>G</given-names></name><name><surname>Dzien</surname><given-names>A</given-names></name><name><surname>Sturm</surname><given-names>W</given-names></name><etal/></person-group><article-title>Changes of serum antibodies to heat-shock protein 65 in coronary
heart disease and acute myocardial infarction</article-title><source>Atherosclerosis</source><year>1996</year><volume>126</volume><issue>2</issue><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">8902159</pub-id></element-citation></ref><ref id="r57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dohke</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>A</given-names></name><name><surname>Isono</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Tsutamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Proteomic analysis reveals significant alternations of cardiac
small heat shock protein expression in congestive heart
failure</article-title><source>J Card Fail</source><year>2006</year><volume>12</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16500585</pub-id></element-citation></ref><ref id="r58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Okauchi</surname><given-names>M</given-names></name><name><surname>Keep</surname><given-names>RF</given-names></name><name><surname>Xi</surname><given-names>G</given-names></name><name><surname>Hua</surname><given-names>Y</given-names></name></person-group><article-title>Deferoxamine affects heat shock protein expression in heart after
intracerebral hemorrhage in aged rats</article-title><source>Acta Neurochir Suppl</source><year>2011</year><volume>111</volume><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">21725755</pub-id></element-citation></ref><ref id="r59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boluyt</surname><given-names>MO</given-names></name><name><surname>Brevick</surname><given-names>JL</given-names></name><name><surname>Rogers</surname><given-names>DS</given-names></name><name><surname>Randall</surname><given-names>MJ</given-names></name><name><surname>Scalia</surname><given-names>AF</given-names></name><name><surname>Li</surname><given-names>ZB</given-names></name></person-group><article-title>Changes in the rat heart proteome induced by exercise training:
Increased abundance of heat shock protein hsp20</article-title><source>Proteomics</source><year>2006</year><volume>6</volume><issue>10</issue><fpage>3154</fpage><lpage>3169</lpage><pub-id pub-id-type="pmid">16586429</pub-id></element-citation></ref><ref id="r60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almela</surname><given-names>P</given-names></name><name><surname>Mart&#x000ed;nez-Laorden</surname><given-names>E</given-names></name><name><surname>Atucha</surname><given-names>NM</given-names></name><name><surname>Milan&#x000e9;s</surname><given-names>MV</given-names></name><name><surname>Laorden</surname><given-names>ML</given-names></name></person-group><article-title>Naloxone-precipitated morphine withdrawal evokes phosphorylation
of heat shock protein 27 in rat heart through extracellular signal-regulated
kinase</article-title><source>J Mol Cell Cardiol</source><year>2011</year><volume>51</volume><issue>1</issue><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">21530534</pub-id></element-citation></ref><ref id="r61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latif</surname><given-names>N</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name><name><surname>Dunn</surname><given-names>MJ</given-names></name></person-group><article-title>Association of pretransplant anti-heart antibodies against human
heat shock protein 60 with clinical course following cardiac
transplantation</article-title><source>Transplant Proc</source><year>1997</year><volume>29</volume><issue>1-2</issue><fpage>1039</fpage><lpage>1040</lpage><pub-id pub-id-type="pmid">9123188</pub-id></element-citation></ref><ref id="r62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>HA</given-names></name><name><surname>Schmid</surname><given-names>KW</given-names></name><name><surname>Schmid</surname><given-names>C</given-names></name><name><surname>Blasius</surname><given-names>S</given-names></name><name><surname>Heinecke</surname><given-names>A</given-names></name><name><surname>Kerber</surname><given-names>S</given-names></name><etal/></person-group><article-title>Possible relationship between heat shock protein 70, cardiac
hemodynamics, and survival in the early period after heart
transplantation</article-title><source>Transplantation</source><year>1998</year><volume>65</volume><issue>6</issue><fpage>799</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">9539091</pub-id></element-citation></ref><ref id="r63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothenbacher</surname><given-names>D</given-names></name><name><surname>Hoffmeister</surname><given-names>A</given-names></name><name><surname>Bode</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Brenner</surname><given-names>H</given-names></name></person-group><article-title>Helicobacter pylori heat shock protein 60 and risk of coronary
heart disease: a case control study with focus on markers of systemic
inflammation and lipids</article-title><source>Atherosclerosis</source><year>2001</year><volume>156</volume><issue>1</issue><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">11369014</pub-id></element-citation></ref><ref id="r64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veres</surname><given-names>A</given-names></name><name><surname>Szamosi</surname><given-names>T</given-names></name><name><surname>Ablonczy</surname><given-names>M</given-names></name><name><surname>Szamosi Jr</surname><given-names>T</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Kar&#x000e1;di</surname><given-names>I</given-names></name><etal/></person-group><article-title>Complement activating antibodies against the human 60 kDa heat
shock protein as a new independent family risk factor of coronary heart
disease</article-title><source>Eur J Clin Invest</source><year>2002</year><volume>32</volume><issue>6</issue><fpage>405</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">12059985</pub-id></element-citation></ref><ref id="r65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genth-Zotz</surname><given-names>S</given-names></name><name><surname>Bolger</surname><given-names>AP</given-names></name><name><surname>Kalra</surname><given-names>PR</given-names></name><name><surname>von Haehling</surname><given-names>S</given-names></name><name><surname>Doehner</surname><given-names>W</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Heat shock protein 70 in patients with chronic heart failure:
relation to disease severity and survival</article-title><source>Int J Cardiol</source><year>2004</year><volume>96</volume><issue>3</issue><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">15301893</pub-id></element-citation></ref><ref id="r66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Shimoda</surname><given-names>Y</given-names></name><name><surname>Akatsu</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Minami</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group><article-title>Elevated circulating levels of heat shock protein 70 are related
to systemic inflammatory reaction through monocyte Toll signal in patients
with heart failure after acute myocardial infarction</article-title><source>Eur J Heart Fail</source><year>2006</year><volume>8</volume><issue>8</issue><fpage>810</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">16714144</pub-id></element-citation></ref><ref id="r67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gombos</surname><given-names>T</given-names></name><name><surname>F&#x000f6;rh&#x000e9;cz</surname><given-names>Z</given-names></name><name><surname>Pozsonyi</surname><given-names>Z</given-names></name><name><surname>J&#x000e1;noskuti</surname><given-names>L</given-names></name><name><surname>Proh&#x000e1;szka</surname><given-names>Z</given-names></name></person-group><article-title>Interaction of serum 70-kDa heat shock protein levels and HspA1B
(+1267) gene polymorphism with disease severity in patients with chronic
heart failure</article-title><source>Cell Stress Chaperones</source><year>2008</year><volume>13</volume><issue>2</issue><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">18759004</pub-id></element-citation></ref><ref id="r68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafarzadeh</surname><given-names>A</given-names></name><name><surname>Esmaeeli-Nadimi</surname><given-names>A</given-names></name><name><surname>Shariati</surname><given-names>M</given-names></name></person-group><article-title>High sensitivity C-reactive protein and immunoglobulin G against
Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart
disease</article-title><source>Iran J Immunol</source><year>2008</year><volume>5</volume><issue>1</issue><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">18319525</pub-id></element-citation></ref><ref id="r69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niizeki</surname><given-names>T</given-names></name><name><surname>Takeishi</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Nitobe</surname><given-names>J</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Relation of serum heat shock protein 60 level to severity and
prognosis in chronic heart failure secondary to ischemic or idiopathic
dilated cardiomyopathy</article-title><source>Am J Cardiol</source><year>2008</year><volume>102</volume><issue>5</issue><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">18721521</pub-id></element-citation></ref><ref id="r70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Elevated heat shock protein 60 levels are associated with higher
risk of coronary heart disease in Chinese</article-title><source>Circulation</source><year>2008</year><volume>118</volume><issue>25</issue><fpage>2687</fpage><lpage>2693</lpage><pub-id pub-id-type="pmid">19106391</pub-id></element-citation></ref><ref id="r71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>MA</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Joint effects of antibody to heat shock protein 60, hypertension,
and diabetes on risk of coronary heart disease in Chinese</article-title><source>Clin Chem</source><year>2008</year><volume>54</volume><issue>6</issue><fpage>1046</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">18436716</pub-id></element-citation></ref><ref id="r72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahsepar</surname><given-names>AA</given-names></name><name><surname>Mirzaee</surname><given-names>A</given-names></name><name><surname>Moodi</surname><given-names>F</given-names></name><name><surname>Moohebati</surname><given-names>M</given-names></name><name><surname>Tavallaie</surname><given-names>S</given-names></name><name><surname>Eshraghi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Anti-heat shock protein 27 titers and oxidative stress levels are
elevated in patients with valvular heart disease</article-title><source>Angiology</source><year>2012</year><volume>63</volume><issue>8</issue><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">22267846</pub-id></element-citation></ref><ref id="r73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Lizano</surname><given-names>P</given-names></name><name><surname>Laure</surname><given-names>L</given-names></name><name><surname>Sui</surname><given-names>X</given-names></name><name><surname>Rashed</surname><given-names>E</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><etal/></person-group><article-title>H11 kinase/heat shock protein 22 deletion impairs both nuclear
and mitochondrial functions of STAT3 and accelerates the transition into
heart failure on cardiac overload</article-title><source>Circulation</source><year>2011</year><volume>124</volume><issue>4</issue><fpage>406</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">21747053</pub-id></element-citation></ref></ref-list></back></article>